[THE USE OF SYNAPLEG, A HUNGARIAN GANGLIONIC-BLOCKING AGENT, IN PERIPHERAL CIRCULATORY DISEASES].
D001162:Arteriosclerosis Obliterans; D003327:Coronary Disease; D004692:Endarteritis; D005492:Folic Acid; D005730:Ganglionic Blockers; D008209:Lymphedema; D009203:Myocardial Infarction; D010393:Pempidine; D011666:Pulmonary Valve Stenosis; D013328:Strophanthins; D013565:Sympatholytics; D014043:Tolazoline; D014116:Toxicology; D014803:Vitamin B Complex
D005730:Ganglionic Blockers; D013328:Strophanthins; D013565:Sympatholytics; D014803:Vitamin B Complex; D005492:Folic Acid; D014043:Tolazoline; D010393:Pempidine
ARTERIOSCLEROSIS OBLITERANS; CORONARY DISEASE; ENDARTERITIS; GANGLIONIC BLOCKADERS; LYMPHEDEMA; MYOCARDIAL INFARCT; PEMPIDINE; PULMONARY VALVE STENOSIS; STROPHANTHIN; SYMPATHOLYTICS; TOLAZOLINE; TOXICOLOGIC REPORT; VITAMIN B COMPLEX
HAZAI GANGLIONB'EN'IT'O--SYNAPLEG--ALKALMAZ'ASA PERIPHERI'AS KERING'ESI ZAVAROKBAN.